We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW YORK, Nov. 23 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Safety First Trust Series 2007-4 Principal-Protected Trust Certificates Linked to a Global...
Akorn, Inc. (AMEX: AKN) today announced that it has signed an Exclusive Supply Agreement with PrimaPharm, Inc., a privately-held pharmaceutical company located in San Diego...
Akorn, Inc. (AMEX:AKN) today announced that its common stock listing application for the Nasdaq Global Market (Nasdaq) has been approved. Akorn expects to begin trading on the...
Akorn, Inc. (AMEX: AKN) today announced the positive results of a Phase III pivotal trial for Akten?. The clinical trial was a randomized, placebo controlled, multi-centered...
Akorn, Inc. (AMEX: AKN) today announced that it has signed a Definitive Agreement with Azad Pharma, a privately-held pharmaceutical company located in Toffen, Switzerland, to...
Akorn, Inc. (AMEX: AKN) and Strides Arcolab Limited (NSE: STAR, BSE: 532531) today announced that both Companies have agreed to fund, develop, and commercialize an additional 10...
Akorn, Inc. (AMEX:AKN) and Serum Institute of India, Ltd. today announced that they have entered into a Definitive Development and Exclusive Distribution Agreement for Rabies...
Akorn, Inc. (AMEX: AKN) today announced that it has added two injectable drug products to its API Supply and Margin Sharing Agreement with Natco Pharma Limited (NSE:...
Akorn, Inc. (AMEX:AKN) today reported net sales of $14.5 million for the third quarter 2006, an increase of 32% vs. third quarter 2005 net sales of $11.0 million. Gross profit...
Akorn, Inc. (AMEX:AKN) announced today that its third quarter 2006 earnings release has been scheduled for Monday, October 30, 2006, at 4:00 p.m. (Eastern Time). The Company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Symbol | Price | Vol. |
---|---|---|
UVIX2x Long VIX Futures ETF | US$ 3.215 (8.25%) | 91.17M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6.00 (3.27%) | 81.21M |
OPTTOcean Power Technologies Inc | US$ 0.4711 (3.97%) | 80.41M |
KULRKULR Technology Group Inc | US$ 4.66 (-2.92%) | 74.65M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2.195 (10.03%) | 64.49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions